Lymphedema Diagnostics Market by Technology (MRI, Lymphoscintigraphy, Ultrasound, Near IR Fluorescence Imaging), Disease Type (Cardiovascular, Cancer, Inflammatory Diseases, Filariasis), End User (Diagnostic Centers, Hospitals) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: May 28, 2019
Clear
SKU: GMS1172 Category:

The global market size for lymphedema diagnostics is expected to reach USD 35.21 million by 2024, rising to CAGR 7.43% during the forecast period. The increasing global prevalence of lymphedema and cancer; technological advances in the modalities of diagnostic imaging, and grants from public-private organizations are the main factors driving this market’s growth.

Lymphedema Diagnostics Market by Technology (MRI, Lymphoscintigraphy, Ultrasound, Near IR Fluorescence Imaging), Disease Type (Cardiovascular, Cancer, Inflammatory Diseases, Filariasis), End User (Diagnostic Centers, Hospitals) - 2019 to 2024 1

Lymphedema Diagnostics Market by Technology (MRI, Lymphoscintigraphy, Ultrasound, Near IR Fluorescence Imaging), Disease Type (Cardiovascular, Cancer, Inflammatory Diseases, Filariasis), End User (Diagnostic Centers, Hospitals) - 2019 to 2024 2

Lymphedema Diagnostics Market by Technology (MRI, Lymphoscintigraphy, Ultrasound, Near IR Fluorescence Imaging), Disease Type (Cardiovascular, Cancer, Inflammatory Diseases, Filariasis), End User (Diagnostic Centers, Hospitals) - 2019 to 2024 3

Lymphedema Diagnostics Market by Technology (MRI, Lymphoscintigraphy, Ultrasound, Near IR Fluorescence Imaging), Disease Type (Cardiovascular, Cancer, Inflammatory Diseases, Filariasis), End User (Diagnostic Centers, Hospitals) - 2019 to 2024 4

Lymphedema Diagnostics Market by Technology (MRI, Lymphoscintigraphy, Ultrasound, Near IR Fluorescence Imaging), Disease Type (Cardiovascular, Cancer, Inflammatory Diseases, Filariasis), End User (Diagnostic Centers, Hospitals) - 2019 to 2024 5

Lymphedema Diagnostics Market by Technology (MRI, Lymphoscintigraphy, Ultrasound, Near IR Fluorescence Imaging), Disease Type (Cardiovascular, Cancer, Inflammatory Diseases, Filariasis), End User (Diagnostic Centers, Hospitals) - 2019 to 2024 6

Lymphedema Diagnostics Market by Technology (MRI, Lymphoscintigraphy, Ultrasound, Near IR Fluorescence Imaging), Disease Type (Cardiovascular, Cancer, Inflammatory Diseases, Filariasis), End User (Diagnostic Centers, Hospitals) - 2019 to 2024 7

Lymphedema Diagnostics Market by Technology (MRI, Lymphoscintigraphy, Ultrasound, Near IR Fluorescence Imaging), Disease Type (Cardiovascular, Cancer, Inflammatory Diseases, Filariasis), End User (Diagnostic Centers, Hospitals) - 2019 to 2024 8

1 Global Lymphedema Diagnostics Market 
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Lymphedema Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Lymphedema Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Lymphedema Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Lymphedema Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Lymphedema Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Lymphedema Diagnostics Market – By Technology (Market Size – & million/billion)
8.1 Lymphoscintigraphy
8.2 Magnetic Resonance Imaging
8.3 Ultrasound Imaging
8.4 Bioimpedance Analysis
8.5 Computed Tomography
8.6 X-Ray Lymphography
8.7 Others

9 Global Lymphedema Diagnostics Market – By Disease Type (Market Size – & million/billion)
9.1 Cancer
9.2 Inflammatory Diseases
9.3 Cardiovascular Disease
9.4 Others

10 Global Lymphedema Diagnostics Market – By End User
10.1 Hospitals
10.2 Diagnostic Centers
10.3 Research & Academic Institutes
10.4 Other

11 Global Lymphedema Diagnostics Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Lymphedema Diagnostics Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Lymphedema Diagnostics Market- Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 GE Healthcare
13.3 Siemens Healthineers (A Subsidiary of Siemens Group)
13.4 Shimadzu Corporation
13.5 United Imaging Healthcare Co., Ltd.
13.6 Stryker Corporation
13.7 Fluoptics
13.8 Philips
13.9 Canon, Inc.
13.10 Hitachi, Ltd.
13.11 Esaote SPA
13.12 Company 11 & more

14 Global Lymphedema Diagnostics Market – Appendix
14.1 Sources
14.2 Abbreviations